XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Income/(Loss) and Comprehensive Income/(Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Oct. 31, 2021
Oct. 31, 2020
Income Statement [Abstract]        
Net sales $ 230,479 $ 248,729 $ 505,088 $ 478,614
Cost of sales 128,484 147,656 273,151 285,117
Gross profit 101,995 101,073 231,937 193,497
Operating expenses:        
Research and development 1,744 1,855 3,552 3,761
Selling, marketing, and distribution 11,423 11,614 22,057 21,609
General and administrative 23,436 23,224 41,049 45,007
Total operating expenses 36,603 36,693 66,658 70,377
Operating income from continuing operations 65,392 64,380 165,279 123,120
Other income/(expense), net:        
Other income/(expense), net 833 693 1,493 760
Interest expense, net (466) (1,490) (1,011) (2,806)
Total other income/(expense), net 367 (797) 482 (2,046)
Income from continuing operations before income taxes 65,759 63,583 165,761 121,074
Income tax expense 14,824 14,465 37,944 28,657
Income from continuing operations 50,935 49,118 127,817 92,417
Discontinued operations:        
Income from discontinued operations, net of tax 3,123 8,209
Net income $ 50,935 $ 52,241 $ 127,817 $ 100,626
Net income per share:        
Basic - continuing operations $ 1.06 $ 0.88 $ 2.65 $ 1.66
Basic - net income 1.06 0.93 2.65 1.81
Diluted - continuing operations 1.05 0.87 2.63 1.64
Diluted - net income $ 1.05 $ 0.92 $ 2.63 $ 1.78
Weighted average number of common shares outstanding:        
Basic 48,147 55,914 48,270 55,691
Diluted 48,692 56,531 48,524 56,475